Table 1 The characteristics of participants.
Healthy (n = 19) | DWoWS* (n = 40) | DWWS**(n = 31) | |
|---|---|---|---|
Age (mean ± SE***) | 37 ± 6 | 32 ± 14 | 34 ± 15 |
Female (%) | 9 (43) | 10 (25) | 13 (41.9) |
NS1 positive (%) | 40 (100) | 31 (100) | |
IgM positive | 40 (100) | 31 (100) | |
IgG positive | 0 | 0 | |
PCR positive (%) | 40 (100) | 28 (90.3) | |
Serotype DENV-1 | 10 (25) | 2 (6.5)# | |
Serotype DENV-2 | 20 (50) | 22 (70.9) | |
Serotype DENV-3 | 3 (7.5) | 3 (9.7) | |
Serotype DENV-4 | 7 (17.5) | 4 (12.9) | |
Comorbidity, n (%) | 5 (12.5) | 3 (9.7) | |
Diabetes | 3 (7.5) | 0 (0) | |
Hypertension | 5 (12.5) | 3 (9.7) | |
Symptoms, n (%) | |||
Fever | 40 (100) | 31 (100) | |
Anorexia | 35 (87.5) | 31 (100) | |
Nausea | 24 (60) | 31 (100) | |
Vomiting | 7 (17.5) | 20 (64.5) | |
Abdominal pain | 3 (7.5) | 25 (80.6)# | |
Diarrhea | 4 (10) | 7 (22.5) | |
Myalgia | 30 (75) | 29 (93.5) | |
Rash | 6 (15) | 4 (12.9) | |
Mucosal bleeding | 0 (0) | 10 (32.3)# | |
Fluid accumulation | 0 (0) | 5 (16.1)# | |